John D. Clements

19.7k total citations · 3 hit papers
209 papers, 15.7k citations indexed

About

John D. Clements is a scholar working on Infectious Diseases, Endocrinology and Immunology. According to data from OpenAlex, John D. Clements has authored 209 papers receiving a total of 15.7k indexed citations (citations by other indexed papers that have themselves been cited), including 72 papers in Infectious Diseases, 64 papers in Endocrinology and 54 papers in Immunology. Recurrent topics in John D. Clements's work include Escherichia coli research studies (60 papers), Viral gastroenteritis research and epidemiology (60 papers) and Neuroscience and Neuropharmacology Research (33 papers). John D. Clements is often cited by papers focused on Escherichia coli research studies (60 papers), Viral gastroenteritis research and epidemiology (60 papers) and Neuroscience and Neuropharmacology Research (33 papers). John D. Clements collaborates with scholars based in United States, Australia and United Kingdom. John D. Clements's co-authors include Gary L. Westbrook, Richard A. Finkelstein, John M. Bekkers, Lucy C. Freytag, Robin A. J. Lester, Craig E. Jahr, Hugh S. Mason, Charles J. Arntzen, Christian Rosenmund and Gang Tong and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

John D. Clements

208 papers receiving 15.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Time Course of Glutamate in the Synaptic Cleft

1992 846 citations John D. Clements et al. profile →
Nonuniform Probability of Glutamate Release at a Hippocampal Synapse

1993 515 citations John D. Clements et al. profile →
Transmitter timecourse in the synaptic cleft: its role in central synaptic function

1996 511 citations John D. Clements Trends in Neurosciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
John D. Clements United States	67	5.7k	5.2k	3.6k	3.1k	3.1k	209	15.7k
Frank M. Collins United States	57	3.3k 0.6×	3.8k 0.7×	4.1k 1.1×	2.6k 0.8×	839 0.3×	196	15.2k
Howard R. Morris United Kingdom	77	15.0k 2.6×	5.8k 1.1×	1.6k 0.4×	3.1k 1.0×	581 0.2×	338	27.0k
Atsushi Yamashita Japan	43	4.5k 0.8×	1.5k 0.3×	785 0.2×	810 0.3×	929 0.3×	171	11.0k
Robert H. Yolken United States	91	7.5k 1.3×	1.4k 0.3×	5.3k 1.5×	2.0k 0.7×	525 0.2×	617	30.3k
Horst Bluethmann Switzerland	64	6.4k 1.1×	3.3k 0.6×	972 0.3×	8.1k 2.6×	260 0.1×	132	19.6k
John Bienenstock Canada	84	10.7k 1.9×	2.0k 0.4×	1.6k 0.4×	6.9k 2.2×	401 0.1×	323	26.6k
Alison D. O’Brien United States	73	2.9k 0.5×	369 0.1×	9.6k 2.6×	2.8k 0.9×	12.1k 3.9×	201	17.3k
Daniel Poulain France	66	4.2k 0.7×	4.1k 0.8×	4.5k 1.2×	1.5k 0.5×	122 0.0×	312	16.4k
Phillip K. Peterson United States	75	3.6k 0.6×	3.0k 0.6×	3.1k 0.8×	3.6k 1.2×	391 0.1×	274	17.6k
Ralf Kühn Germany	64	11.2k 2.0×	3.6k 0.7×	888 0.2×	8.4k 2.7×	210 0.1×	234	25.8k

Countries citing papers authored by John D. Clements

Since Specialization

Citations

This map shows the geographic impact of John D. Clements's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John D. Clements with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John D. Clements more than expected).

Fields of papers citing papers by John D. Clements

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John D. Clements. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John D. Clements. The network helps show where John D. Clements may publish in the future.

Co-authorship network of co-authors of John D. Clements

This figure shows the co-authorship network connecting the top 25 collaborators of John D. Clements. A scholar is included among the top collaborators of John D. Clements based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John D. Clements. John D. Clements is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Clements, John D., et al.. (2025). Protective antibodies against enterotoxigenic Escherichia coli are generated from heat-labile toxoid vaccination and exhibit subject- and vaccine-specific diversity. Medical Microbiology and Immunology. 214(1). 10–10. 1 indexed citations

Chaudhary, Omkar, Lingling Wang, Deepanwita Bose, et al.. (2020). Comparative Evaluation of Prophylactic SIV Vaccination Modalities Administered to the Oral Cavity. AIDS Research and Human Retroviruses. 36(12). 984–997. 4 indexed citations

McLaughlin, C., John D. Clements, Ana‐Maria Oprişoreanu, & Sergiy Sylantyev. (2019). The role of tonic glycinergic conductance in cerebellar granule cell signalling and the effect of gain‐of‐function mutation. The Journal of Physiology. 597(9). 2457–2481. 5 indexed citations

Clements, John D., et al.. (2019). Population Pharmacokinetics of Blinatumomab in Pediatric and Adult Patients with Hematological Malignancies. Clinical Pharmacokinetics. 59(4). 463–474. 13 indexed citations

Norton, Elizabeth B., et al.. (2015). The novel adjuvant dmLT promotes dose sparing, mucosal immunity and longevity of antibody responses to the inactivated polio vaccine in a murine model. Vaccine. 33(16). 1909–1915. 66 indexed citations

Lundgren, Anna, Louis Bourgeois, Nils Carlin, et al.. (2014). Safety and immunogenicity of an improved oral inactivated multivalent enterotoxigenic Escherichia coli (ETEC) vaccine administered alone and together with dmLT adjuvant in a double-blind, randomized, placebo-controlled Phase I study. Vaccine. 32(52). 7077–7084. 104 indexed citations

Holmgren, Jan, Louis Bourgeois, Nils Carlin, et al.. (2013). Development and preclinical evaluation of safety and immunogenicity of an oral ETEC vaccine containing inactivated E. coli bacteria overexpressing colonization factors CFA/I, CS3, CS5 and CS6 combined with a hybrid LT/CT B subunit antigen, administered alone and together with dmLT adjuvant. Vaccine. 31(20). 2457–2464. 107 indexed citations

Arifuzzaman, Mohammad, Rasheduzzaman Rashu, Daniel T. Leung, et al.. (2012). Antigen-Specific Memory T Cell Responses after Vaccination with an Oral Killed Cholera Vaccine in Bangladeshi Children and Comparison to Responses in Patients with Naturally Acquired Cholera. Clinical and Vaccine Immunology. 19(8). 1304–1311. 28 indexed citations

Lawson, Louise B., Elizabeth B. Norton, & John D. Clements. (2011). Defending the mucosa: adjuvant and carrier formulations for mucosal immunity. Current Opinion in Immunology. 23(3). 414–420. 107 indexed citations

10.

Lu, Ying‐Jie, Puja Yadav, John D. Clements, et al.. (2010). Options for Inactivation, Adjuvant, and Route of Topical Administration of a Killed, Unencapsulated Pneumococcal Whole-Cell Vaccine. Clinical and Vaccine Immunology. 17(6). 1005–1012. 84 indexed citations

11.

Verdonck, Frank, Petra Tiels, Bruno Goddeeris, et al.. (2007). Mucosal immunization of piglets with purified F18 fimbriae does not protect against F18+ Escherichia coli infection. Veterinary Immunology and Immunopathology. 120(3-4). 69–79. 36 indexed citations

12.

Choi, Anthony H.-C., Mitali Basu, Monica McNeal, et al.. (2007). Protection of mice against rotavirus challenge following intradermal DNA immunization by Biojector needle-free injection. Vaccine. 25(16). 3215–3218. 21 indexed citations

13.

McNeal, Monica, Susan Stone, Mitali Basu, et al.. (2007). IFN-γ Is the Only Anti-rotavirus Cytokine Found after In Vitro Stimulation of Memory CD4 ⁺ T Cells from Mice Immunized with a Chimeric VP6 Protein. Viral Immunology. 20(4). 571–584. 23 indexed citations

14.

McNeal, Monica, Mitali Basu, Judy A. Bean, et al.. (2007). Intrarectal immunization of mice with VP6 and either LT(R192G) or CTA1-DD as adjuvant protects against fecal rotavirus shedding after EDIM challenge. Vaccine. 25(33). 6224–6231. 39 indexed citations

15.

McNeal, Monica, Susan Stone, Mitali Basu, et al.. (2006). Protection against rotavirus shedding after intranasal immunization of mice with a chimeric VP6 protein does not require intestinal IgA. Virology. 346(2). 338–347. 31 indexed citations

16.

Ambrose, Zandrea, Kay Larsen, LaRene Kuller, et al.. (2003). Evidence for immune-mediated reduction of viral replication in Macaca nemestrina mucosally immunized with inactivated SHIV89.6. Virology. 308(1). 178–190. 3 indexed citations

17.

Cheng, Elly, et al.. (1999). The role of cAMP in mucosal adjuvanticity of Escherichia coli heat-labile enterotoxin (LT). Vaccine. 18(1-2). 38–49. 82 indexed citations

18.

Ryan, Edward T., et al.. (1999). In Vivo Expression and Immunoadjuvancy of a Mutant of Heat-Labile Enterotoxin of Escherichia coli in Vaccine and Vector Strains of Vibrio cholerae. Infection and Immunity. 67(4). 1694–1701. 2 indexed citations

19.

Clements, John D.. (1996). Transmitter timecourse in the synaptic cleft: its role in central synaptic function. Trends in Neurosciences. 19(5). 163–171. 511 indexed citations breakdown →

20.

Mant, David, Godfrey Fowler, Peter Burke, et al.. (1993). Effectiveness of a nicotine patch in helping people stop smoking: results of a randomised trial in general practice. Imperial Cancer Research Fund General Practice Research Group.. BMJ. 306(6888). 1304–1308. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact